DNS - Ustekinumab 45 mg
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1688/2021/ÚVN + 12-171/2021-1470 | 25. 11. 2021 | Janssen-Cilag s.r.o. | 18 713 870,03 | 17 012 609,12 | 18 713 870,03 | 17 012 609,12 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| VNOL Smlouva anonymized.pdf | Smlouva | 08. 12. 2021 11:25 | Dokument není zavirovaný |
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| Janssen-Cilag s.r.o. | Praha |
Price Actually Paid in Each Year of Performance
| 1688/2021/ÚVN + 12-171/2021-1470 | 2023 | 3 508 859,36 | 3 189 871,36 |
| 1688/2021/ÚVN + 12-171/2021-1470 | 2022 | 3 077 947,92 | 2 798 134,50 |
| 1688/2021/ÚVN + 12-171/2021-1470 | 2021 | 615 590,03 | 559 627,30 |